Craig Hendrix, MD
Director, Drug Development Unit
Professor, Medicine (Clinical Pharmacology, Infectious Diseases) and Pharmacology and Molecular Sciences, and Epidemiology (Bloomberg School of Public Health)

Johns Hopkins University
600 N. Wolfe Street, Harvey 502
Baltimore, MD 21287-5554
Phone: 410-955-9707
Fax: 410-955-9708

Email: chendrix@jhmi.edu

Research Interests:
Chemoprevention of HIV infection; topical HIV microbicides; clinical pharmacology of antiviral drugs; drug interactions

Selected Publications:
Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, Wahl RL, Hendrix CW (2007, Epub 2007 Jan 23). Hyperosmolar Sexual Lubricant Causes Epithelial Damage in the Distal Colon: Potential Implication for HIV Transmission. J Infect Dis 195(5):703-710.

Hendrix CW, Fuchs EJ, Macura KJ, Lee LA, Parsons TL, Bakshi RP, Khan WA, Guidos A, Leal JP, Wahl R (2008 epub 2007 May 16). Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates. Clin Pharmacol Ther Jan; 83(1):97-105.

Choi L, Caffo BS, Rohde C, Ndovi TT, Hendrix CW (2008). A Mechanistic Latent Variable Model for Estimating Drug Concentrations in the Male Genital Tract: A Case Study in Drug Kinetics. Stat Med Jun 30; 27(14):2697-714.

Cao Y-J, Hendrix CW (2008 epub 2007 Oct 5). Male Genital Tract Pharmacology: Developments in Quantitative Methods to Better Understand a Complex Peripheral Compartment. Clin Pharmacol Ther . Mar;83(3):401-12.

Hendrix CW, Cao YJ, Fuchs EJ (2009). Topical Microbicides to Prevent HIV: Clinical Drug Development Challenges. Ann Rev Pharmacol Toxicol; 49:349–75.

Return to Faculty Home